Pharmerging

World Market Report

MCP16682

EXECUTIVE ENGAGEMENTS

POOL

14103
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1692
Interactions with Platform & by Email

PARTICIPANTS

423
Unique # Participated

VALIDATIONS

89
Responses Validated*

COMPANIES

22
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2023

TABLES

123

PAGES

184

EDITION

9

PRICE

USD 4950

CODE

MCP16682


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
»Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
»Online interactive peer-to-peer collaborative bespoke updates
»Access to our digital archives and MarketGlass Research Platform
»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Pharmerging Market to Reach $1.6 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Pharmerging estimated at US$735.5 Million in the year 2022, is projected to reach a revised size of US$1.6 Billion by 2030, growing at aCAGR of 9.9% over the period 2022-2030. Pharmaceutical, one of the segments analyzed in the report, is projected to record 8.4% CAGR and reach US$951.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Healthcare segment is readjusted to a revised 12.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $215.2 Million, While China is Forecast to Grow at 9.3% CAGR
The Pharmerging market in the U.S. is estimated at US$215.2 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$270.4 Million by the year 2030 trailing a CAGR of 9.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.6% and 8.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

SELECT PLAYERS

Abbott Laboratories; AbbVie, Inc.; Alexion Pharmaceuticals, Inc.; Allergan PLC; Amgen, Inc.; Aspen Pharmacare Holdings Ltd.; Astellas Pharma, Inc.; AstraZeneca PLC; Baxter International, Inc.; Bayer AG; Biogen, Inc.; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; Celgene Corporation; CSL Behring; Daiichi Sankyo Co., Ltd.; Eisai Co., Ltd.; Eli Lilly and Company; Endo International PLC; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Grifols SA; H. Lundbeck A/S; Hospira, Inc.; Johnson & Johnson; Kyowa Hakko Kirin Co., Ltd.; Mallinckrodt Pharmaceuticals; Mitsubishi Tanabe Pharma Corporation; Mylan Pharmaceutical Pvt. Ltd.; Novartis AG; Novo Nordisk A/S; Otsuka Pharmaceutical Co., Ltd.; Pfizer, Inc.; Sanofi SA; Shire PLC; Stada Arzneimittel AG; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Co., Ltd.; Teva Pharmaceutical Industries Ltd.; UCB SA

SEGMENTS

» Product (Pharmaceutical, Healthcare)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Pharmerging Market to Grow Steadily, Driven by Rapid Growth of the Pharma Sector
Table: Worldwide Pharmaceutical Market Growth Projections by Regional Group: 2018 and 2022
Table: Breakdown of Growth Percentage and Spending in Billion USD for Pharmerging Markets by Country: 2007-2022
Pharmerging – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Pharmaceutical Segment to Register Strong Growth
Table: Total Spending on Medicines (in Billion USD) in Select Emerging Pharmaceutical Markets: 2023
Table: Healthcare Market in Tier I Pharmerging Region (USD Billion) by Product: 2014-2025
Asia-Pacific Region to Retain Top Slot
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Geriatric Population to Bode Well for Market Growth
Table: Total Breakdown of People Aged Over 60 by Development Groups: 1980 to 2050
Increase in Patient Numbers to Support Market Growth
Table: Top Therapeutic Areas by Spending (Billion USD) in Pharmerging Markets: 2018
Table: Select Therapy Areas Spending (Billion USD) in Pharmerging Markets: 2020
Increasing Preference for Generics to Spur Market Expansion
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Pharmerging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Pharmerging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2027
World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Recent Past, Current & Future Analysis for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
World Pharmerging Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2027
UNITED STATES
Pharmerging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
JAPAN
Pharmerging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
CHINA
Pharmerging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
EUROPE
Pharmerging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Pharmerging by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Pharmerging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2021 & 2027
Europe Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
FRANCE
Pharmerging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
GERMANY
Pharmerging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
UNITED KINGDOM
Pharmerging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
ASIA-PACIFIC
Pharmerging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Pharmerging by Product - Pharmaceutical and Healthcare - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Pharmerging by Product - Percentage Breakdown of Value Sales for Pharmaceutical and Healthcare for the Years 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com